Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2362-2026

Brand Name: EXENT Analyser Product Name: EXENT Analyser Recall

Brand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20 Product Description: The EXENT Analyser is an automated analyser intended for the qualitative and quantitative in vitro measurement of analytes in human body fluids used in conjunction with the EXENT assays.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: EXENT Analyser Product Name: EXENT Analyser. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2362-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 16, 2026
FDA report date
Jun 17, 2026
Quantity in commerce
1
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20 Product Description: The EXENT Analyser is an automated analyser intended for the qualitative and quantitative in vitro measurement of analytes in human body fluids used in conjunction with the EXENT assays.

Affected model & UDI checker

Search the exact identifiers published for Z-2362-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
IE800.ABrand Name: EXENT Analyser Product Name: EXENT AnalyserCheck source noticeNot specified
Not specifiedBrand Name: EXENT Analyser Product Name: EXENT AnalyserCheck source notice05051700020886
FDA code information

Lot Code: Model No; IE800A; EXENT Analyser; UDI; 05051700020886, Serial Number; 101150, Software version; v1.0.20.

View the original FDA recall notice

Why was this product recalled?

It was reported that plates 2 and 3 were marked as passed , although it appeared that QC had not been performed on these plates, despite samples being measured. The potential clinical hazards include false or missed detection of M-protein (false positive); and falsely elevated or decreased M-protein concentration.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did The Binding Site Group, Ltd. take?

Firm notified customers via "Urgent Medical Device Correction" letter dated April 14, 2026. Customers were advised to confirm QC results are present in the QC results screen for the corresponding plate barcode after the completion of each plate measurement. If no QC result is displayed, do not release results from that plate and repeat the run ensuring QC material is properly loaded. The customer should also contact US Technical Support. When performing multi-plate runs while loading a previously used QC vials, ensure newly opened QCs are loaded onto Reagent Runner 2 as well, or discard and load newly opened QC vials into Reagent Runner 1. Retrospective review of previously released results is not considered necessary by the recalling firm. Please maintain awareness of the issue until Thermo Fisher Scientific identifies and implements a software enhancement that addresses the issue.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology